| 1 | Breast Cancer and Hormonal Contraceptives: Collaborative Reanalysis of Individual Data on 53 297 Women With Breast Cancer and 100 239 Women Without Breast Cancer From 54 Epidemiological Studies | 1996 | 1,301 |
| 2 | Free Cortisol Levels After Awakening: A Reliable Biological Marker for the Assessment of Adrenocortical Activity | 1997 | 1,271 |
| 3 | Combined Oral Contraceptives in Women With Systemic Lupus Erythematosus | 2005 | 1,112 |
| 4 | Risk of Idiopathic Cardiovascular Death and Nonfatal Venous Thromboembolism in Women Using Oral Contraceptives With Differing Progestagen Components. | 1995 | 700 |
| 5 | Randomised Controlled Trial of Levonorgestrel Versus the Yuzpe Regimen of Combined Oral Contraceptives for Emergency Contraception | 1998 | 676 |
| 6 | Hormonal Contraception and Risk of Venous Thromboembolism: National Follow-Up Study | 2009 | 616 |
| 7 | Association of Hormonal Contraception With Depression | 2016 | 575 |
| 8 | The Venous Thrombotic Risk of Oral Contraceptives, Effects of Oestrogen Dose and Progestogen Type: Results of the MEGA Case-Control Study | 2009 | 571 |
| 9 | Thromboembolic Disease and the Steroidal Content of Oral Contraceptives. A Report to the Committee on Safety of Drugs | 1970 | 522 |
| 10 | Effect of Different Progestagens in Low Oestrogen Oral Contraceptives on Venous Thromboembolic Disease. World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. | 1995 | 520 |
| 11 | Low Dose Mifepristone and Two Regimens of Levonorgestrel for Emergency Contraception: A WHO Multicentre Randomised Trial | 2002 | 519 |
| 12 | Liver-Cell Adenomas Associated With Use of Oral Contraceptives | 1976 | 516 |
| 13 | Oral Contraceptives and the Risk of Venous Thrombosis | 2001 | 515 |
| 14 | Possible Association Between Benign Hepatomas and Oral Contraceptives. | 1973 | 511 |
| 15 | Classification and Pharmacology of Progestins | 2003 | 496 |
| 16 | Ulipristal Acetate Versus Levonorgestrel for Emergency Contraception: A Randomised Non-Inferiority Trial and Meta-Analysis | 2010 | 476 |
| 17 | Levonorgestrel-Releasing and Copper-Releasing (Nova T) IUDs During Five Years of Use: A Randomized Comparative Trial | 1994 | 459 |
| 18 | Dissonance and the Pill: An Attribution Approach to Studying the Arousal Properties of Dissonance. | 1974 | 458 |
| 19 | Cervical Cancer and Hormonal Contraceptives: Collaborative Reanalysis of Individual Data for 16 573 Women With Cervical Cancer and 35 509 Women Without Cervical Cancer From 24 Epidemiological Studies | 2007 | 450 |
| 20 | Etiology, Management, and Outcome of the Budd-Chiari Syndrome | 2009 | 448 |
| 21 | Steroid Research at Syntex: “The Pill” and Cortisone | 1992 | 447 |
| 22 | Women's Trials: The Approval of the First Oral Contraceptive Pill in the United States and Great Britain. | 2002 | 434 |
| 23 | Serum High-Density-Lipoprotein Cholesterol in Women Using Oral Contraceptives, Estrogens and Progestins | 1978 | 426 |
| 24 | Oral Contraceptives and Cardiovascular Disease | 1981 | 420 |
| 25 | Oral Contraceptive Discontinuation: A Prospective Evaluation of Frequency and Reasons | 1998 | 404 |
| 26 | The Safety of a Drospirenone-Containing Oral Contraceptive: Final Results From the European Active Surveillance Study on Oral Contraceptives Based on 142,475 Women-Years of Observation | 2007 | 403 |
| 27 | The Effects of Different Formulations of Oral Contraceptive Agents on Lipid and Carbohydrate Metabolism | 1990 | 400 |
| 28 | Steroids and “the Pill”: Early Steroid Research at Searle | 1992 | 393 |
| 29 | On the History of Hormonal Contraception I. Ludwig Haberlandt (1885–1932) and His Concept of “Hormonal Sterilization” | 1970 | 386 |
| 30 | On the History of Hormonal Contraception II. Otfried Otto Fellner (1873-19??) And Estrogens as Antifertility Hormones | 1971 | 381 |
| 31 | A New Derivative of Triphenylethylene: Effect on Implantation and Mode of Action in Rats. | 1967 | 380 |
| 32 | Investigation of Relation Between Use of Oral Contraceptives and Thromboembolic Disease. | 1968 | 372 |
| 33 | Drospirenone: Pharmacology and Pharmacokinetics of a Unique Progestogen | 2000 | 366 |
| 34 | The Hormonal Activity of the Postmenopausal Ovary. | 1976 | 364 |
| 35 | Polycystic Ovarian Syndrome (PCOS): Long-Term Metabolic Consequences | 2018 | 361 |
| 36 | A Single-Center Surgical Experience of 122 Patients With Single and Multiple Hepatocellular Adenomas | 2009 | 358 |
| 37 | Investigation of Relation Between Use of Oral Contraceptives and Thromboembolic Disease. A Further Report | 1969 | 354 |
| 38 | Oral Contraceptives and the Risk of Myocardial Infarction | 2001 | 352 |
| 39 | Biochemical Pharmacology of Antiestrogen Action. | 1984 | 349 |
| 40 | Third Generation Oral Contraceptives and Risk of Venous Thrombosis: Meta-Analysis | 2001 | 346 |
| 41 | Ischaemic Stroke and Combined Oral Contraceptives: Results of an International, Multicentre, Case-Control Study | 1996 | 345 |
| 42 | P450 Enzymes of Estrogen Metabolism | 1993 | 344 |
| 43 | Progesterone “Block” | 1956 | 341 |
| 44 | Oral Contraceptives and Venous Thrombosis: Different Sensitivities to Activated Protein C in Women Using Second- and Third-Generation Oral Contraceptives | 1997 | 341 |
| 45 | Ischemic Stroke Risk With Oral Contraceptives: A Meta-Analysis | 2000 | 341 |
| 46 | The Effects of Self-Administering Emergency Contraception | 1998 | 333 |
| 47 | Thromboembolism and Oral Contraceptives: An Epidemiologic Case-Control Study. | 1969 | 331 |
| 48 | Radioimmunoassay of Serum Progesterone in Women Receiving Oral Contraceptive Steroids | 1972 | 331 |
| 49 | Myocardial Infarction in Young Women With Special Reference to Oral Contraceptive Practice. | 1975 | 321 |
| 50 | Contraception Selection, Effectiveness, and Adverse Effects: A Review | 2021 | 320 |
| 51 | Acute Myocardial Infarction and Combined Oral Contraceptives: Results of an International Multicentre Case-Control Study | 1997 | 317 |
| 52 | Population-Based Study of Risk of Venous Thromboembolism Associated With Various Oral Contraceptives | 1997 | 313 |
| 53 | Pharmacological Profile of Progestins | 2004 | 306 |
| 54 | The Effect of Combined Oral Contraception on Testosterone Levels in Healthy Women: A Systematic Review and Meta-Analysis. | 2014 | 306 |
| 55 | Mifepristone (RU 486) Compared With High-Dose Estrogen and Progestogen for Emergency Postcoital Contraception | 1992 | 305 |
| 56 | Cardiovascular Disease and Use of Oral and Injectable Progestogen-Only Contraceptives and Combined Injectable Contraceptives: Results of an International, Multicenter, Case-Control Study | 1998 | 303 |
| 57 | Stroke in Users of Low-Dose Oral Contraceptives | 1996 | 302 |
| 58 | Comparison of Ethinylestradiol Pharmacokinetics in Three Hormonal Contraceptive Formulations: The Vaginal Ring, the Transdermal Patch and an Oral Contraceptive | 2005 | 302 |
| 59 | Use and Misuse of Oral Contraceptives: Risk Indicators for Poor Pill Taking and Discontinuation | 1995 | 299 |
| 60 | A Prospective Study of the Effects of Oral Contraceptives on Sexuality and Well-Being and Their Relationship to Discontinuation | 2001 | 297 |
| 61 | Evaluation of Contraceptive Efficacy and Cycle Control of a Transdermal Contraceptive Patch vs an Oral Contraceptive: A Randomized Controlled Trial | 2001 | 296 |
| 62 | Progestogens and Cardiovascular Reactions Associated With Oral Contraceptives and a Comparison of the Safety of 50- and 30-Microgram Oestrogen Preparations. | 1980 | 290 |
| 63 | A Gonadotropin-Releasing Hormone Agonist Versus a Low-Dose Oral Contraceptive for Pelvic Pain Associated With Endometriosis | 1993 | 286 |
| 64 | Can We Identify Women at Risk of Pregnancy Despite Using Emergency Contraception? Data From Randomized Trials of Ulipristal Acetate and Levonorgestrel | 2011 | 279 |
| 65 | Direct Access to Emergency Contraception Through Pharmacies and Effect on Unintended Pregnancy and STIs: A Randomized Controlled Trial | 2005 | 278 |
| 66 | The Effects of Oral Contraceptives on Exercise Performance in Women: A Systematic Review and Meta-Analysis | 2020 | 272 |
| 67 | Continuous Use of an Oral Contraceptive for Endometriosis-Associated Recurrent Dysmenorrhea That Does Not Respond to a Cyclic Pill Regimen | 2003 | 269 |
| 68 | Oral Contraceptives and Death From Myocardial Infarction. | 1975 | 268 |
| 69 | Prospective Study of Oral Contraceptives and Hypertension Among Women in the United States | 1996 | 265 |
| 70 | Association Between the Current Use of Low-Dose Oral Contraceptives and Cardiovascular Arterial Disease: A Meta-Analysis. | 2005 | 264 |
| 71 | Influence of Oral Contraceptive Therapy on the Activity of Systemic Lupus Erythematosus | 1982 | 263 |
| 72 | Cancer Risk Among Users of Oral Contraceptives: Cohort Data From the Royal College of General Practitioner's Oral Contraception Study | 2007 | 259 |
| 73 | Contraceptive Hormone Use and Cardiovascular Disease | 2009 | 258 |
| 74 | Randomised Comparative Trial of the Intrauterine System and Norethisterone Levonor Gestrel for Treatment of Idiopathic Menorrhagia | 1998 | 250 |
| 75 | A Prospective Study of Past Use of Oral Contraceptive Agents and Risk of Cardiovascular Diseases | 1988 | 249 |
| 76 | ACOG Practice Bulletin No. 73: Use of Hormonal Contraception in Women With Coexisting Medical Conditions | 2006 | 248 |
| 77 | Progestin-Only Contraception and Thromboembolism: A Systematic Review | 2016 | 248 |
| 78 | A Decade’s Experience With an Individualized Clomiphene Treatment Regimen Including Its Effect on the Postcoital Test | 1982 | 246 |
| 79 | Clomiphene Citrate: Mechanism(s) and Site(s) of Action—A Hypothesis Revisited | 1984 | 245 |
| 80 | Proniosome Based Transdermal Delivery of Levonorgestrel for Effective Contraception | 1998 | 243 |
| 81 | Oral Contraceptives and Thromboembolic Disease: Effects of Lowering Œstrogen Content | 1980 | 242 |
| 82 | A Multicenter, Randomized Study of an Extended Cycle Oral Contraceptive | 2003 | 242 |
| 83 | A Prospective Randomized Comparison of Levonorgestrel With the Yuzpe Regimen in Post-Coital Contraception | 1993 | 241 |
| 84 | Timing of Emergency Contraception With Levonorgestrel or the Yuzpe Regimen | 1999 | 241 |
| 85 | Ethinylestradiol and Dl-Norgestrel as a Postcoital Contraceptive | 1977 | 238 |
| 86 | Resistance to Activated Protein C as a Basis for Venous Thromboembolism Associated With Pregnancy and Oral Contraceptives | 1995 | 237 |
| 87 | History of Oral Contraceptive Drugs and Their Use Worldwide | 2013 | 236 |
| 88 | Hormone Withdrawal Symptoms in Oral Contraceptive Users | 2000 | 234 |
| 89 | Plasma Concentrations of Free and Non-TeBG Bound Testosterone in Women on Oral Contraceptives | 1974 | 233 |
| 90 | Oral Contraceptive Pills as Primary Prevention for Ovarian Cancer: A Systematic Review and Meta-Analysis | 2013 | 233 |
| 91 | A Prospective Comparison of Bone Density in Adolescent Girls Receiving Depot Medroxyprogesterone Acetate (Depo-Provera), Levonorgestrel (Norplant), or Oral Contraceptives | 1996 | 232 |
| 92 | Effect of Four Different Oral Contraceptives on Various Sex Hormones and Serum-Binding Globulins | 2003 | 232 |
| 93 | To What Extent Do Oral Contraceptives Influence Mood and Affect? | 2002 | 231 |
| 94 | Health During Prolonged Use of Levonorgestrel 20 μg/d and the Copper TCu 380Ag Intrauterine Contraceptive Devices: A Multicenter Study | 1994 | 230 |
| 95 | The Efficacy of Intrauterine Devices for Emergency Contraception: A Systematic Review of 35 Years of Experience | 2012 | 230 |
| 96 | Lifetime Cancer Risk and Combined Oral Contraceptives: The Royal College of General Practitioners’ Oral Contraception Study | 2017 | 230 |
| 97 | Reprint of Classification and Pharmacology of Progestins | 2008 | 226 |
| 98 | Pharmacokinetics of Etonogestrel and Ethinylestradiol Released From a Combined Contraceptive Vaginal Ring | 2000 | 225 |
| 99 | Bone Density in Women Receiving Depot Medroxyprogesterone Acetate for Contraception. | 1991 | 224 |
| 100 | Oral Contraceptives and Stroke in Young Women: Associated Risk Factors | 1975 | 223 |